,
Dutch East IndiesUnder the
Guided Democracy period, the Indonesian government nationalized this branch into
Bio Farma. , ca.1900 The Institut Pasteur was founded in 1887 by the French chemist and microbiologist
Louis Pasteur. He was committed both to basic research and its practical applications. From the start, Pasteur brought together scientists with various specialties. The first five departments were directed by two
normaliens (graduates of the
École Normale Supérieure),
Émile Duclaux (general microbiology research) and
Charles Chamberland (microbes research applied to hygiene), a biologist,
Ilya Ilyich Mechnikov (morphological microbe research), and two physicians,
Jacques-Joseph Grancher (rabies) and
Emile Roux (technical microbe research). One year after the inauguration of the Institut Pasteur, Roux set up the first course of
microbiology ever taught in the world,
Cours de Microbie Technique (Course of microbe research techniques). Pasteur's successors have sustained this tradition, which is reflected in the Institut Pasteur's unique history of accomplishment: • Emile Roux and
Alexandre Yersin discovered the mechanism of action of
Corynebacterium diphtheriae and how to treat diphtheria with
antitoxins •
Alexandre Yersin discovered in 1894 the pathogen of
bubonic plague,
Yersinia pestis •
Paul-Louis Simond discovered in 1898 the role of the
flea in the transmission of plague •
Albert Calmette and
Camille Guérin discovered how to culture the
tuberculosis bacillus,
Mycobacterium tuberculosis (so-called BCG or
Bacillus Calmette-Guérin) at
Institut Pasteur de Lille, and developed in 1921 the first effective anti-tuberculosis vaccine •
Alphonse Laveran received the
1907 Nobel Prize for his research on the role of
protozoans as disease agents (notably, his discovery of the
malaria hematozoon) •
Ilya Ilyich Mechnikov received the Nobel Prize in 1908 for contributions to the scientific understanding of the
immune system •
Constantin Levaditi and
Karl Landsteiner demonstrated in 1910 that
poliomyelitis is due to a filterable virus •
Félix d'Herelle discovered in 1917 the
bacteriophage, a virus that spread only inside bacteria •
Jules Bordet received the Nobel prize in 1919 for his discoveries on
immunity, especially the implication of
antibodies and the
complement system′s mechanisms of action •
Charles Nicolle received the Nobel prize in 1928 for explaining how
typhus is transmitted, especially the role of the
louse •
Jean Laigret developed the first vaccine for
yellow fever in 1932. •
André Lwoff established the existence of
proviruses in 1951, and the work honored by the 1965 Nobel Prize. •
Jacques Monod and
Francois Jacob discovered the mechanism of genes'
transcription regulation, a work honored by the 1965 Nobel Prize • Pierre Lépine developed in 1955 one of the first anti-polio vaccines •
Jean-Pierre Changeux isolated the first receptor to a
neurotransmitter, the
acetylcholine receptor in 1970. •
Luc Montagnier,
Françoise Barré-Sinoussi and colleagues discovered the two HIV viruses that cause
AIDS in 1983 and 1985; Montagnier and Barré-Sinoussi were honored by the 2008 Nobel Prize A new age of
preventive medicine in France was made possible by the Institut Pasteur's (early 20th century) development of vaccines for
tuberculosis,
diphtheria,
tetanus,
yellow fever and
poliomyelitis. The discovery and use of
sulfonamides in treating infections was another of its earlier breakthroughs. Some researchers discovered
antitoxins, while
Daniel Bovet received the 1957 Nobel Prize for his discoveries on synthetic anti-histamines and
curarizing compounds. Since
World War II, Pasteur researchers have focused on
molecular biology. Their achievements were recognized in 1965, when the Nobel Prize was shared by
François Jacob,
Jacques Monod and
André Lwoff for their work on the regulation of
viruses. In 1985, the first human vaccine obtained by genetic engineering from animal cells, the vaccine against hepatitis B, was developed by Pierre Tiollais and collaborators.
Opening The center against rabies, directed by Jacques-Joseph Grancher and Émile Roux, had become so overcrowded that it became necessary to build a structure that Pasteur had been using the name "Institute Pasteur" long before it was even built. Pasteur delegated the task of the project and of creating the new building, situated on rue Dutot, to two of his colleagues, Grancher and
Emile Duclaux. From the beginning, the Institute experienced economic difficulties for which it needed the help of the government, some foreign rulers, and Madame Boucicaut, but this aid did not affect its independence. The statutes drawn by Pasteur and later approved by Duclaux and Grancher define, besides its absolute freedom and independence, the institute's internal structure: a rabies division controlled by Grancher, anthrax one in
Chamberland's hands, who also supervised the department of microbiology, while Emile Roux dealt with microbial methods applied to medicine.
World War I and II During the First World War, the Pasteur Institute prioritized vaccinating troops against the easily contractable
typhoid fever. By September 1914, the institute was able to provide 670,000 doses of the vaccine and continued to produce it throughout the conflict.
Gabriel Bertrand, with Roux's authorization, crafted a grenade based on chloropicrin and
Fourneau discovered the chemical reaction that led to the formation of methylarsine chloride. In 1921,
Albert Simard edited the ''La réaction de fixation de l'alexine: son application au diagnostic sérologique de la peste,'' "work of the Pasteur Institute in Paris, plague laboratory." In 1938, the institute, despite its relative poverty, built a biochemical division and another one dedicated to cellular pathology, whose direction was entrusted to the hands of
Boivin (who went on to discover endotoxins that are contained in the germ's body and are freed after its death). During the same period, Andre Lwoff assumed the direction of a new microbial physiology branch built on rue Dutot. The institute deposited the complete sequences of the virus samples taken from two of the first French cases on the
GISAID database platform. The institute has also been involved in research and development of
testing and epidemiological modelling, including in
Africa via its network institutions. In 2020, Pasteur was involved in the development of a
COVID-19 vaccine in partnership with
Merck & Co., but this was abandoned in January 2021 after unsuccessful
clinical trials.
Institute Pasteur in Cambodia was a key institution involved in the public health response during the
COVID-19 pandemic in Cambodia, as well as conducting research into SARS-CoV-2.
Pasteur Institute of Dakar were also involved in
Senegal's health response. ==Accomplishments of the Institute's members==